U.S. public investment in clean energy RD&D lags behind Asian competitors, which are already seeing a payoff in both research output and commercial success.
For the sake of both future global innovation and for the interests of consumers and patients worldwide, we must stay the course on robust IP protections in the Trans-Pacific Partnership, writes Stephen Ezell in The Hill.
The public and private sectors need to work in tandem to realize the next generation of medicine and health care and overcome the institutional challenges that increasingly hinder progress toward precision medicine.
U.S. and EU policymakers will have to get data privacy and trade policies right if they want to maximize the growth potential of the transatlantic marketplace writes Stephen Ezell in Innovation Files.
Vilifying the H-1B visa as a scapegoat for America’s stubbornly slow-to-improve unemployment rate ignores the immense economic benefits for both firms and workers, writes Adams Nager in IndustryWeek.
Those on the left don’t believe raising productivity would do any good. Those on the right don’t think it can be done anyway. Both are wrong, writes Rob Atkinson in the Christian Science Monitor.